| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |